ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾 疾病预防与控制 Disease Prevention and Control 医学学术期刊 月刊
2026-07-028 临床药物与手术治疗 2026, 2(07): 109-112

肿瘤标志物联合临床参数鉴别肺腺体前驱病变及肺腺癌浸润性

苏州市立医院(南京医科大学附属苏州医院)

0下载次数 0被引频次 1阅读次数 19参考文献
知网阅读全文
摘要

目的 评价癌胚抗原(CEA)、鳞状细胞癌抗原(SCCA)、神经元特异性烯醇化酶(NSE)、糖类抗原125(CA125)、细胞角蛋白19片段(CYFRA21-1)、人附睾蛋白4(HE4)联合年龄、肿瘤最大径鉴别Ⅰ期肺腺癌与肺腺体前驱病变(PGL)及判断浸润程度的效能。方法 比较87例Ⅰ期肺腺癌与30例PGL患者上述指标,采用受试者工作特征(ROC)曲线评价诊断效能,并比较PGL、微浸润性腺癌(MIA)及浸润性腺癌(IAC)三组差异。结果 Ⅰ期肺腺癌组年龄、最大径、CEA、HE4、CYFRA21-1均高于PGL组(P<0.05);联合诊断曲线下面积(AUC)为0.852。年龄、最大径、CEA、HE4随浸润程度增加,CYFRA21-1仅IAC组高于PGL组。结论联合检测可辅助鉴别PGL与Ⅰ期肺腺癌并判断浸润程度。

Abstract

Objective To evaluate carcinoembryonic antigen(CEA), squamous cell carcinoma antigen(SCCA), neuron-specific enolase(NSE), carbohydrate antigen 125(CA125), cytokeratin 19 fragment(CYFRA21-1), human epididymis protein 4(HE4), age, and maximum tumor diameter for differentiating stage I lung adenocarcinoma from pulmonary glandular precursor lesions(PGL) and assessing invasion. Methods Eight indicators were compared between 87 adenocarcinoma and 30 PGL cases. Receiver operating characteristic(ROC) curves assessed diagnostic performance. PGL, minimally invasive adenocarcinoma(MIA), and invasive adenocarcinoma(IAC) were compared. Results Age, maximum diameter, CEA, HE4, and CYFRA21-1 were higher in adenocarcinoma than those in the PGL group(P<0.05). Combined area under the curve(AUC) was 0.852. Age, maximum diameter, CEA, and HE4 increased with invasion. CYFRA21-1 was higher only in IAC than PGL. Conclusion Combined detection may assist differential diagnosis between PGL and stage I lung adenocarcinoma and invasion assessment.

引用本文

按标准格式复制,或导出到文献管理软件
[1]黄安康,吴献华,成刚,等.肿瘤标志物联合临床参数鉴别肺腺体前驱病变及肺腺癌浸润性[J].疾病预防与控制,2026,2(07):109-112.